Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1863-2025Class II

GM Helix Acqua Implant, Article Number: 140.985

Straumann USA, LLC / initiated 2025-05-01 / Open, Classified / root cause: labeling and UDI

Straumann USA LLC began a recall of GM Helix Acqua Implant, Article Number: 140.985 on . FDA classified it as Class II and gives the reason as "It is possible that a package labelled as an 11.5 mm implant may contain a 13 mm implant instead". As of , the recall status on record is Open, Classified, and MDM tags the root cause as labeling and UDI.

Recall record

Recall number
Z-1863-2025
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Straumann USA, LLC
Product
GM Helix Acqua Implant, Article Number: 140.985
Product code
DZE Implant, Endosseous, Root-Form
Reason for recall
It is possible that a package labelled as an 11.5 mm implant may contain a 13 mm implant instead.
Root cause tag
labeling and UDI
FDA root cause
Under Investigation by firm
Action
On May 1, 2025 URGENT FIELD SAFETY ACTION letters were sent to customers. Action to be taken: 1. If article 140.984 Lot JPZ21 or 109.985 Lot JPZ75 are still in your inventory, then stop use/distribution of the product immediately and quarantine/segregate physically. 2. If the product was used and no complications or problems were identified, of the patient did not present symptoms there is no need for any additional action with the patient. 3. If article 140.984 Lot JPZ21 or 109.985 Lot JPZ75 are still in your inventory, return it for a credit or replacement as indicated on the Customer Confirmation Form. 4. In the product is not found in your stock, indicate this on the enclosed Customer Confirmation Form. 5 In all cases, complete and return the enclosed Customer Confirmation Form with the affected product using the return UPS label provided to: Straumann USA, LLC; 60 Minuteman Road, Andover, MA 01810. Transmission of the Field Safety Notice: This notice needs to be passed on to all those who need to be aware within your organization or to any organization where the affected devices have been transferred. The FDA has been informed about this Field Safety Corrective Action. We apologize for any inconvenience that this may cause.
Quantity in commerce
207 units (54 US, 153 OUS)
Distribution
Worldwide - US Nationwide distribution in the states of AZ, CA, CO, FL, GA, Il KS, LA, MA, MD, MI, NE, NH, NJ, NY, OH, OK, RI, SC, TN, TX, UT, WI and the countries of Australia, Croatia, France, Hungary, India, Italy, Lebanon, Lithuania, New Zealand, Portugal, Qatar, Serbia, Spain, Tunisia, UAE, United Kingdom, Vietnam.
Product codes and lots
Article Number: 140.985; UDI-DI: (01)7899878024569(11)220125(17)270124(10)JPZ75; Lot number: JPZ75;

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1863-2025
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1862-2025Class IIOngoingVoluntary: Firm initiated
Z-1863-2025Class IIOngoingVoluntary: Firm initiated